nafronyl has been researched along with Cerebrovascular Disorders in 17 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It covers firstly the general problems of stroke, dementia and 'common symptoms' of the elderly, and then looks in detail at those compounds which have to date attracted most attention (ergot derivatives, cinnarizine, flunarizine, vincamine, eburnamonine, naftidrofuryl, oxpentifylline, piracetam and citicoline), as well as those which are currently considered investigational (choline and lecithin)." | 6.15 | 'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders. ( Spagnoli, A; Tognoni, G, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (70.59) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spagnoli, A | 1 |
| Tognoni, G | 1 |
| Kobayashi, S | 1 |
| Yamaguchi, S | 1 |
| Katsube, T | 1 |
| Okada, K | 1 |
| Kitani, M | 1 |
| Murao, M | 1 |
| Tsunematsu, T | 1 |
| Cook, P | 1 |
| James, I | 1 |
| Drummond, M | 1 |
| Davies, L | 1 |
| Akopov, SE | 1 |
| Darbinian, VZh | 1 |
| Ovanesian, GO | 1 |
| Admani, AK | 1 |
| Perkin, GD | 1 |
| Judge, TG | 1 |
| Steiner, T | 1 |
| Capildeo, R | 1 |
| Rose, FC | 1 |
| Cox, JR | 1 |
| Steiner, TJ | 2 |
| Capon, A | 1 |
| Lehert, P | 1 |
| Opsomer, L | 1 |
| Gray, CS | 1 |
| French, JM | 1 |
| Venables, GS | 1 |
| Cartlidge, NE | 1 |
| James, OF | 1 |
| Bates, D | 1 |
| Sandercock, P | 1 |
4 reviews available for nafronyl and Cerebrovascular Disorders
| Article | Year |
|---|---|
'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.
Topics: Adult; Aged; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Cytidine Diphosphate | 1983 |
Drug therapy: cerebral vasodilators (first of two parts).
Topics: Aged; Aging; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cycla | 1981 |
Naftidrofuryl after acute stroke: a review and a hypothesis.
Topics: Acute Disease; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Nafronyl | 1990 |
Naftidrofuryl (Praxilene).
Topics: Acute Disease; Cerebrovascular Disorders; Dementia; Furans; Humans; Nafronyl | 1988 |
11 trials available for nafronyl and Cerebrovascular Disorders
| Article | Year |
|---|---|
'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.
Topics: Adult; Aged; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Cytidine Diphosphate | 1983 |
Effects of naftidrofuryl on the time course of the regional cerebral blood flow in acute ischemic stroke.
Topics: Adult; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascular Disorders; | 1984 |
Drug therapy: cerebral vasodilators (first of two parts).
Topics: Aged; Aging; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cycla | 1981 |
New approach to treatment of recent stroke.
Topics: Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Female; Furans; Huma | 1978 |
New approach to treatment of recent stroke?
Topics: Cerebral Hemorrhage; Cerebral Infarction; Cerebrovascular Disorders; Clinical Trials as Topic; Drug | 1979 |
Treatment of acute stroke.
Topics: Cerebrovascular Disorders; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; Glycerol; H | 1979 |
Double-blind evaluation of naftidrofuryl in treating elderly confused hospitalised patients.
Topics: Aged; Attitude of Health Personnel; Cerebrovascular Disorders; Clinical Trials as Topic; Cognition D | 1975 |
Naftidrofuryl in the treatment of subacute stroke.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Double-Blind Method; Femal | 1990 |
A randomized double-blind controlled trial of naftidrofuryl in acute stroke.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Cerebrovascular Disorders; Delayed-Action Preparat | 1990 |
Naftidrofuryl in the treatment of recent stroke. Results of a controlled clinical trial.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Cerebrovascular Disorders; Clinical Trials as Topi | 1988 |
Important new treatments for acute ischaemic stroke?
Topics: Acute Disease; Cerebrovascular Disorders; Clinical Trials as Topic; Glycerol; Humans; Nafronyl; Nimo | 1987 |
4 other studies available for nafronyl and Cerebrovascular Disorders
| Article | Year |
|---|---|
Economic evaluation of drugs in peripheral vascular disease and stroke.
Topics: Cerebrovascular Disorders; Cost-Benefit Analysis; Decision Trees; Economics, Pharmaceutical; Health | 1994 |
[Blood filterability and its correction with naftidrofuril in patients with cerebrovascular diseases].
Topics: Acute Disease; Aged; Brain Ischemia; Cerebrovascular Disorders; Drug Evaluation; Erythrocyte Deforma | 1996 |
The therapeutic uses of naftidrofuryl (Praxilene)--cerebrovascular disease.
Topics: Aged; Animals; Cerebrovascular Disorders; Dementia; Furans; Humans; Nafronyl | 1978 |
New approach to treatment of recent stroke.
Topics: Cerebrovascular Disorders; Furans; Humans; Nafronyl; Research Design | 1979 |